Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 688 participants.
Also called NCT05105633
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 688 participants
- Sponsor
- Registry
-
NCT05105633
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Australia, Brazil, France
- Registry status
- Recruiting
Technical summary
Registry record NCT05105633. Randomized; no masking; primary purpose treatment. Start 2021-11-29 (actual); primary completion 2028-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke
- Acronym
- POST-ETERNAL
- Condition
- Basilar Artery Occlusion
- Intervention (Drug)
- Tenecteplase
- Intervention (Drug)
- Standard Care (which may include intravenous Alteplase)
- Lead sponsor
- University of Melbourne
Record details
- Record id
cardio:ct-nct05105633- Content hash
b308fb0a875b3d1b18dafb3ba31b2df4be38db370db721b8df713224b55ae055